Description: XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Home Page: www.xoma.com
XOMAP Technical Analysis
2200 Powell Street
EmeryVille,
CA
94608
United States
Phone:
510 204 7200
Officers
| Name | Title |
|---|---|
| Mr. James R. Neal M.B.A., M.S. | CEO & Chairman |
| Mr. Thomas M. Burns | Sr. VP of Fin. & CFO |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 24.4655 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-12-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 12 |